The CAR-T cell therapy workflow

10 Jun 2019

Clinical

Find out more about the CAR-T cell therapy workflow in this informative infographic from Bio-Rad Laboratories (CA, USA). Discover some of the challenges associated with CAR-T cell R&D as well as technologies and reagents used for bioanalytical analysis.

CLICK HERE TO DOWNLOAD THE INFOGRAPHIC

Previous article Next article

											
										18 DEC 2019
																					INTERVIEWS
																			
										Generating custom antibodies for bioanalytical research: an interview with Ulrich Mayer
									
										14 MAY 2019
																					INTERVIEWS
																			
										CAR-T cell development: an interview with Michael Schwenkert
									
										5 JAN 2018
																					INTERVIEWS
																			
										Drug-target complex specific antibodies: an interview with Michael Schwenkert (Bio-Rad)
									
										23 JAN 2017
																					ANTIBODIES | ADCS
																			
										Interview with Michael Schwenkert (Bio-Rad Laboratories) on best practices for the characterization and quality control of anti-idiotypic antibodies for bioanalysis
									
										19 DEC 2023
																					INTERVIEWS
																			
										AAPS 2023: interviews from the floor with Dominic Warrino
									
										8 JAN 2019
																					INTERVIEWS
																			
										Anti-idiotypic antibodies and CAR-T cell therapies with Michael Schwenkert